AzTrials
AzTrials

Spinal Cord Injuries (SCI)NCT06777576

Self-balancing Personal Exoskeleton for SCI

A study testing Hands-free exoskeleton in people with Spinal Cord Injuries (SCI) and Paraplegia and Tetraplegia, run by Wandercraft at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to demonstrate the safety and effectiveness of the Eve personal exoskeleton in individuals with spinal cord injury (SCI). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Hands-free exoskeleton
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
27 participants
Where
1 siteUnited States
Study dates
12 Feb 2025to 24 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

SCI user inclusion Criteria:

  • Any gender, age 18 years or older;
  • Motor complete or incomplete SCI with lesions at or above T6;
  • ≥ 6 months post SCI;
  • Able and willing to attend 9 to 10 visits1 to the center, including sessions of training and assessments of one-to-three hours duration;
  • Able to read, understand, and provide informed consent;
  • Living in the US and speaks English.

SCI user exclusion Criteria:

  • Diagnosis of neurological injury other than SCI;
  • Progressive condition that would be expected to result in changing neurological status;
  • Severe concurrent medical disease, illness or condition judged to be contraindicated by the site physician;
  • Unhealed or unstable traumatic or high impact lower extremity fracture of any duration that is, in the clinical judgement of the study physician, exclusionary for standing and walking;
  • Knee (proximal tibia and/or distal femur) BMD <0.60 gm/cm2;
  • Total hip BMD T-scores < -3.5;
  • Fragility, minimal trauma, or low impact fracture of the lower extremity since SCI;
  • Untreatable severe spasticity judged to be contraindicated by the site physician;
  • Untreated/uncontrolled hypertension, as judged to be contraindicated by the site physician;
  • Unresolved orthostatic hypotension (change from baseline seated BP to a fall in 20mmHg SBP and/or fall in 10mmHG DBP and symptoms when standing), or as judged to be contraindicated by the site physician;
  • Open or unhealed skin pressure sores, abrasions, or bruises at any of the contact points of the exoskeleton;
  • Morphological contraindications to the use of the device;
  • Uncorrectable leg length discrepancy over 2 cm (about 0.79 in) when using additional correction tools;
  • Unable to effectively operate the device with a hand-control interface, due to functional and/or cognitive impairment, evaluated based on the ability to manipulate the joystick in all direction, press and identify buttons on the hand control interface.
  • Improper fitting in the device;
  • Psychopathology documentation in the medical record that may conflict with study objectives;
  • Pregnancy or women who plan to become pregnant during the study period;
  • Concurrent participation in another interventional trial;
  • History of uncontrolled autonomic dysreflexia;
  • Presence colostomy and/or urostomy;
  • Ventilator use at the time of the exoskeleton use.

Companion inclusion Criteria:

  • Any gender, age 18 years or older;
  • Willingness to attend 9 to 10 visits to the center, including sessions of training and assessments of one-to-three hours duration with the SCI user;
  • Able to read, understand and provide informed consent;
  • Living in the US and speaks English.

Companion exclusion Criteria:

  • Inability to communicate with an assistant due to cognitive and language disorders;
  • Any disease, concomitant injury, or condition that interferes with the performance or interpretation of the protocol- specified assessments;
  • Insufficient strength and performance capability, evidenced by the ability to hold and retain the device in case of unbalance/fall;
  • Insufficient availability to complete the study;
  • Concurrent participation in another interventional trial.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • James J. Peters, VA Medical Center, Bronx, NY

    The Bronx, New York, 10468-3904

Other trials in United States

About this study

Official title: Empowering Mobility in People With Spinal Cord Injury With a Hands-free, Self-balancing Personal Exoskeleton

This study aims to demonstrate the safety and effectiveness of the Eve personal exoskeleton in individuals with spinal cord injury (SCI).

Read the detailed description

This personal exoskeleton, developed by Wandercraft as a new version of the Atalante X, offers a novel hands-free and self-balancing design, aiming at enhancing stability and mobility for users in daily activities.

The study features an interventional, prospective, single-group, and open-label design, conducted over 3 to 4 weeks at two US research facilities. 24 subjects are required to complete the study. Anticipating a 15% dropout rate, the study will enroll 29 participants.

Over the course of nine to ten scheduled visits, participants undergo a sequence of procedures, beginning with screening and device fitting. This is followed by five training sessions which conclude with an evaluation to issue a competency certificate to confirm the ability to use the device across all its "basic skills". Additionally, two sessions are dedicated to evaluating the exoskeleton's effectiveness outcomes, complemented by an extra practice session. Each visit lasts an average of 1.5 hours.

Being tested
Hands-free exoskeleton
Keywords
Spinal Cord Injury, Robotics, Hands-free exoskeleton, Overground exoskeleton, Walking, Self-balancing, personal use, home
Medical subject headings
Spinal Cord Injuries, Paraplegia, Quadriplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hands-free exoskeletonDevice

    A "device trainer specialist" from the investigation site will deliver training sessions with the exoskeleton to pair of participants (a pair corresponds to an individual with SCI and his/her companion). The device trainer will follow the progression of the pair through the training program and ensure they learn all the device "basic skills". Each training session lasts an average of 1.5 hours, variations according to the user's learning pace and tolerance. During the sessions with the exoskeleton, the participants will engage in mobility activities on different surfaces and perform Activities of Daily Living in simulated environments such as kitchen, bathroom, elevators and outdoor spaces.

Study groups in NCT06777576
Study groupRoleWhat they receive
Hands-free exoskeletonExperimentalNot described
Receives: Device: Hands-free exoskeleton

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less.

    The TUG evaluates the time from starting in a seated position to stand-up, walk 3 meters, turn around, walk back 3 meters and sit down on indoor surface.

    Measured: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.

  2. Proportion of subjects who complete a distance of at least 40m on the Six-Minute Walk Test (6MWT).

    The 6MWT measures the distance in meters traversed over 6 min, on indoor surface.

    Measured: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.

Secondary outcomes (3)
  1. Proportion of subjects who can complete at least 4 out of the 6 Activities of Daily Living (ADLs), in various simulated environments and with the exoskeleton.

    The ADLs are done standing in front of the countertop in the kitchen, in a simulated living room, taking a 50m walk in the outdoor environment, taking the elevator, in the bathroom and walking in a hallway and through a door to get to the next room.

    Measured: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.

  2. Proportion of subjects who complete the 10-Meter Walk Test (10MWT) on indoor surfaces in 1 minute or less.

    The 10MWT measures the time in seconds taken to walk 10 meters.

    Measured: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.

  3. Proportion of subjects who can don or doff the device within 10 minutes each, separately.

    Measured: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2025
  2. Study start12 Feb 2025
  3. Primary completion10 Jun 2026
  4. Study completion24 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
27 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06777576
Sponsor's protocol ID
CIP007
Status last verified
Oct 2026
First submitted
8 Jan 2025
Last updated
15 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: Individual Participant Data will not be shared.

Questions about this trial

What is this clinical trial studying?

A study testing Hands-free exoskeleton in people with Spinal Cord Injuries (SCI) and Paraplegia and Tetraplegia, run by Wandercraft at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less. (time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in